ArticleKidney medicine2026

Anemia Treatment and Its Clinical Implications in Patients Receiving Hemodialysis Hyporesponsive to Erythropoietin-Stimulating Agents.

James B Wetmore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.